Sensus Healthcare said Q1 2026 was a transition quarter as new dedicated CPT codes for superficial radiotherapy took effect, but revenue declined from the prior year. The company attributed the drop largely to the absence of sales to its historically largest customer. The update points to near-term pressure on operating performance even as reimbursement changes may support future adoption.
Sensus Healthcare said Q1 2026 was a transition quarter as new dedicated CPT codes for superficial radiotherapy took effect, but revenue declined from the prior year. The company attributed the drop largely to the absence of sales to its historically largest customer. The update points to near-term pressure on operating performance even as reimbursement changes may support future adoption.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
